Details for: SEVORANE AF
Company: ABBVIE CORPORATION
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02172763 | SEVORANE AF | SEVOFLURANE | 99.97 % | LIQUID | INHALATION |
Summary Reports
Summary Safety Review - SEVORANE AF (sevoflurane) - Severe low heart rate in children with Down syndrome
Summary Safety Review - Sedative and anesthetic drugs (DIPRIVAN [propofol], KETALAR [ketamine], SEVORANE [sevoflurane], SUPRANE [desflurane], FORANE/ISOFLURANE USP [isoflurane] - Assessing the potential risk of negative effects on the development of children's brains (neurodevelopmental disorders)
Summary Safety Review - Sevoflurane - Re-Assessing the potential risk of slow heartbeat (bradycardia) in children with Down syndrome
Summary Safety Review - Sedative and anesthetic drugs (DIPRIVAN [propofol], KETALAR [ketamine], SEVORANE [sevoflurane], SUPRANE [desflurane], FORANE/ISOFLURANE USP [isoflurane] - Assessing the potential risk of negative effects on the development of children's brains (neurodevelopmental disorders)
Summary Safety Review - Sevoflurane - Re-Assessing the potential risk of slow heartbeat (bradycardia) in children with Down syndrome
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.